Loxapine

Product manufactured by Actavis Pharma, Inc.

Application Nr Approved Date Route Status External Links
ANDA072204 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Loxapine Capsules Are Indicated For The Treatment Of Schizophrenia. The Efficacy Of Loxapine In Schizophrenia Was Established In Clinical Studies Which Enrolled Newly Hospitalized And Chronically Hospitalized Acutely Ill Schizophrenic Patients As Subjects.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Loxapine Succinate LOXAPINE SUCCINATE ZINC895030

Comments